Tanshinone II Is a Potent Candidate for Treatment of Lipopolysaccharide-Induced Acute Lung Injury in Rat Model

Oncology Letters - Greece
doi 10.3892/ol.2017.7581
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Protective Effects of Hesperetin on Lipopolysaccharide-Induced Acute Lung Injury in a Rat Model

Turkish Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2020English

Triptolide Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Rats

European Journal of Medical Research
Medicine
2013English

Sulfur Dioxide Reduces Lipopolysaccharide-Induced Acute Lung Injury in Rats

Central-European Journal of Immunology
AllergyImmunology
2019English

Retraction Note: Triptolide Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Rats

European Journal of Medical Research
Medicine
2015English

Involvement of the Urokinase Kringle Domain in Lipopolysaccharide-Induced Acute Lung Injury

Journal of Immunology
AllergyImmunology
2006English

XB130 Deficiency Enhances Lipopolysaccharide-Induced Septic Response and Acute Lung Injury

Oncotarget
Oncology
2016English

Attenuation of Acute Lung Injury in a Rat Model by Semen Cassiae

BMC Complementary and Alternative Medicine
MedicineAlternative MedicineComplementary
2017English

MiR-342 Attenuates Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting MAPK1 Expression

Clinical and Experimental Pharmacology and Physiology
PhysiologyPharmacology
2020English

Activation of PPARα by Wy-14643 Ameliorates Systemic Lipopolysaccharide-Induced Acute Lung Injury

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy